BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 3480384)

  • 1. Preliminary studies on a more effective phototoxic agent than hematoporphyrin.
    Richter AM; Kelly B; Chow J; Liu DJ; Towers GH; Dolphin D; Levy JG
    J Natl Cancer Inst; 1987 Dec; 79(6):1327-32. PubMed ID: 3480384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Evaluation of Light-Activatable Biohybrids for Anti-Glioma Photodynamic Therapy.
    Inglut CT; Baglo Y; Liang BJ; Cheema Y; Stabile J; Woodworth GF; Huang HC
    J Clin Med; 2019 Aug; 8(9):. PubMed ID: 31438568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for assessing and removing non-specific photoimmunotherapy damage in patient-derived tumor cell culture models.
    Timilsina S; Saad MA; Lang RT; Hasan T; Spring BQ
    Photochem Photobiol; 2024 May; ():. PubMed ID: 38728432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Progress of Metal-Organic Framework-Based Photodynamic Therapy for Cancer Treatment.
    Ye Y; Zhao Y; Sun Y; Cao J
    Int J Nanomedicine; 2022; 17():2367-2395. PubMed ID: 35637838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic Therapy: A Brief History.
    Kessel D
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31581613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal formulations of photosensitizers.
    Ghosh S; Carter KA; Lovell JF
    Biomaterials; 2019 Oct; 218():119341. PubMed ID: 31336279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photosensitizers Used in the Photodynamic Therapy of Rheumatoid Arthritis.
    Gallardo-Villagrán M; Leger DY; Liagre B; Therrien B
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy.
    Lucena SR; Zamarrón A; Carrasco E; Marigil MA; Mascaraque M; Fernández-Guarino M; Gilaberte Y; González S; Juarranz A
    Sci Rep; 2019 Mar; 9(1):4835. PubMed ID: 30886381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-Arterial Drug and Light Delivery for Photodynamic Therapy Using Visudyne®: Implication for Atherosclerotic Plaque Treatment.
    Jain M; Zellweger M; Frobert A; Valentin J; van den Bergh H; Wagnières G; Cook S; Giraud MN
    Front Physiol; 2016; 7():400. PubMed ID: 27672369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indium as a central metal enhances the photosensitizing efficacy of benzoporphyrin derivatives.
    Saenz C; Ethirajan M; Iacobucci G; Pandey A; Missert JR; Dobhal MP; Pandey RK
    J Porphyr Phthalocyanines; 2011 Nov; 15(11n12):1310. PubMed ID: 23275739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic Therapy for Cancer and for Infections: What Is the Difference?
    Sharma SK; Mroz P; Dai T; Huang YY; St Denis TG; Hamblin MR
    Isr J Chem; 2012 Sep; 52(8-9):691-705. PubMed ID: 23248387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How were new medicines discovered?
    Swinney DC; Anthony J
    Nat Rev Drug Discov; 2011 Jun; 10(7):507-19. PubMed ID: 21701501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of resistance to photodynamic therapy.
    Casas A; Di Venosa G; Hasan T; Al Batlle
    Curr Med Chem; 2011; 18(16):2486-515. PubMed ID: 21568910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin.
    Donohue E; Tovey A; Vogl AW; Arns S; Sternberg E; Young RN; Roberge M
    J Biol Chem; 2011 Mar; 286(9):7290-300. PubMed ID: 21193398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy and the development of metal-based photosensitisers.
    Josefsen LB; Boyle RW
    Met Based Drugs; 2008; 2008():276109. PubMed ID: 18815617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spotlight on verteporfin in subfoveal choroidal neovascularisation.
    Keam SJ; Scott LJ; Curran MP
    Drugs Aging; 2004; 21(3):203-9. PubMed ID: 14979737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.
    Keam SJ; Scott LJ; Curran MP
    Drugs; 2003; 63(22):2521-54. PubMed ID: 14609361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy.
    Granville DJ; Jiang H; An MT; Levy JG; McManus BM; Hunt DW
    Br J Cancer; 1999 Jan; 79(1):95-100. PubMed ID: 10408699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BPD-MA-mediated photosensitization in vitro and in vivo: cellular adhesion and beta1 integrin expression in ovarian cancer cells.
    Runnels JM; Chen N; Ortel B; Kato D; Hasan T
    Br J Cancer; 1999 Jun; 80(7):946-53. PubMed ID: 10362101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy using intravenous delta-aminolaevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats.
    Svanberg K; Liu DL; Wang I; Andersson-Engels S; Stenram U; Svanberg S
    Br J Cancer; 1996 Nov; 74(10):1526-33. PubMed ID: 8932330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.